Toumai

Toumai® Surgical Robot, developed by MicroPort® MedBot™, is an advanced and cutting-edge robotic-assisted surgical system designed to enhance the precision, flexibility, and control of surgical procedures.

Toumai Surgical Robot system has received EU CE certification.

Toumai® system is the first in the world to support integration with multiple communication infrastructures, including 5G, broadband, dedicated fiber lines, and satellite communications. This enables highly flexible and cost-effective “one-to-many” and “many-to-many” remote surgical connectivity. As a result, it significantly reduces operational costs and simplifies deployment of telesurgery.

MicroPort® MedBot™ has also established the world’s first and only intercontinental telesurgery network, which currently spans six continents and over 100 countries and regions. To date, nearly 400 tele-surgical procedures have been successfully performed. Network performance tests show that the bidirectional latency is less than 50 milliseconds for inter-provincial procedures and under 150 milliseconds for telesurgeries conducted across telecom carriers, countries, and continents.

It’s a valuable tool for various surgical procedures:

Urology: Robotic assisted radical prostatectomy, Robotic assisted partial nephrectomy, Robotic assisted radical nephrectomy, Robotic assisted radical cystectomy

General surgery: Robotic assisted pancreaticoduodenectomy, Robotic assisted surgeries for thyroid cancer, stomach cancer, gallbladder cancer, low anterior rectal resection, left/right hemicolectomy, partial hepatectomy, partial pancreatectomy

Gynecology: Robotic assisted surgeries for cervical cancer, ovarian cancer, endometrial cancer, pelvic floor reconstruction, Robotic assisted radical hysterectomy, Robotic assisted myomectomy

Thoracic: Robotic assisted surgeries for lung cancer, oesophageal cancer